John Adlesich or the ascent of a healthcare manager professional on healthcare industry trends in 2021: Deeper relationships and back-up suppliers. The value of vendor-of-choice relationships became apparent as many hospitals scrambled for pandemic-related supplies. The key is striking a strategic balance between price, performance and trust. Getting the lowest price but lacking a relationship that cannot be “prioritized” in a crisis is not ideal. Neither is overreliance on one vendor without having plans B, C and D in place. We see many organizations developing connections with tiers of back-up suppliers — often smaller and geographically closer than their primary vendors — to gain flexibility, speed and as much certainty as possible that critical items will be on hand when needed.
John Adlesich on behavior therapy in 2021: ESDM uses behavioral principals to encourage developmental growth in language, cognition, social skills, and the achievement of other developmental milestones. While intensive, ESDM is meant to be enjoyable and can be implemented with very young children and infants. Emphasis is placed on capturing and holding attention through providing enjoyable and meaningful activities. AutismSpeaks.org indicates that ESDM therapy: Is designed to be enjoyable for the child and resembles play more than therapy (though it is therapeutic) Should be developed by trained professionals but can be utilized by all family members as well as other caregivers Can be more even more effective if begun in infancy or early childhood Focuses on capturing and maintaining attention with activities that teach social behaviors, communication, and other socially significant behaviors Choosing the Right Therapies for You and Your Child.
John Adlesich on healthcare industry trends in 2021: The California versus Texas case came to the Supreme Court from a federal appeals court. If the Supreme Court affirms the appeals court ruling, the case will go back to the federal district court to decide on the issue of severability of the individual mandate from the rest of the ACA. At the November 2020 oral argument, it looked like the Supreme Court, including one or more of the new justices, was inclined to honor the doctrine of severability, making it less likely the ACA will face complete repeal. Additionally, the new slim Democratic majority in the Senate (thanks to the Georgia runoff) makes it likely that Congress would fix the constitutional problem by reinstating the mandate with a nominal penalty. John Adlesich currently works as administrator at Marquis Companies. His latest healthcare industry experience includes positions as executive director at Powerback Rehabilitation Lafayette (Genesis Healthcare) between Aug 2020 – Jan 2021, administrator at Mesa Vista of Boulder between Mar 2019 – Aug 2020, chief executive officer at Sedgwick County Memorial Hospital between Jul 2018 – Feb 2019, interim chief operating officer at Toiyabe Indian Health Project between Mar 2018 – Jun 2018.
John Adlesich thinks that 2021 is an important year for the healthcare industry. History gives us many reasons to doubt predictions. In 1916, Charlie Chaplin famously called the motion pictures “a fad.” In 1932, Albert Einstein said that nuclear power was not possible. In 2008, Steve Ballmer predicted the iPhone would be a flop. As these cases show, smart people may see the facts, but not the environmental factors that can shift the entire landscape. This was particularly true in 2020, a year that redefined “normal” and altered our world in ways we are only beginning to understand. In this environment, the hard job of accurately predicting future trends became that much more difficult. When I look back at my own predictions last year, almost none of them played out as I thought due to the pandemic and the complete upending of the national health care agenda. But now 10 months in, the pandemic’s true impact is starting to be understood. For 2021, job number one for the nation will be moving ahead with the largest mass vaccination program in our history, as well as improving our rapid testing capabilities and therapeutic treatments for COVID-19, in order to build our herd immunity and allow us to safely reopen and repair our badly damaged economy. This backdrop will permeate all our decisions this year, and directional trends will largely be influenced by how quickly we make progress in these areas.